These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6151196)

  • 21. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1).
    Erchegyi J; Kastin AJ; Zadina JE
    Peptides; 1992; 13(4):623-31. PubMed ID: 1359507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyr-MIF-1 augments benzodiazepine receptor binding in vivo.
    Miller LG; Kastin AJ; Greenblatt DJ
    Pharmacol Biochem Behav; 1987 Dec; 28(4):521-4. PubMed ID: 2893390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MIF-1 and Tyr-MIF-1 augment muscimol-stimulated chloride uptake in cerebral cortex.
    Miller LG; Kastin AJ; Roy RB
    Brain Res Bull; 1989 Dec; 23(6):413-5. PubMed ID: 2575438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyr-W-MIF-1-induced conditioned place preference.
    Nores WL; Olson RD; Olson GA; Vaccarino AL; Bell RL; Zadina JE; Kastin AJ
    Peptides; 1999; 20(4):479-84. PubMed ID: 10458518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1.
    Erchegyi J; Zadina JE; Qiu XD; Kersh DC; Ge LJ; Brown MM; Kastin AJ
    Pept Res; 1993; 6(1):31-8. PubMed ID: 8094991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products.
    Horowitz D; Callahan JF; Pelus LM; Fukuda S; King AG
    Int Immunopharmacol; 2002 Apr; 2(5):721-30. PubMed ID: 12013510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyr-MIF-1 precipitates abstinence syndrome in morphine-dependent rats.
    Malin DR; Zadina JE; Lake JR; Rogillio RB; Leyva JE; Benson TM; Corriere LS; Handunge BP; Kastin AJ
    Brain Res; 1993 Apr; 610(1):169-71. PubMed ID: 8100171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
    Zadina JE; Kastin AJ; Ge LJ; Hackler L
    Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance and morphine-induced cross-tolerance are not shown to Tyr-W-MIF-1 analgesia.
    Bell RL; Vaccarino AL; Olson RD; Olson GA; Nores WL; Cambre JG; Zadina JE; Kastin AJ
    Peptides; 1999; 20(8):971-8. PubMed ID: 10503776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged analgesia after intracerebroventricular Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2).
    Zadina JE; Kastin AJ; Kenigs V; Bruno C; Hackler L
    Neurosci Lett; 1993 Jun; 155(2):220-2. PubMed ID: 8104325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain peptide reverses effect of morphine on human lymphocytes.
    Strimas JH; Chi DS; Kastin AJ
    Peptides; 1987; 8(6):1165-7. PubMed ID: 2894648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of binding sites for N-Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in rat brain.
    Zadina JE; Kastin AJ; Krieg EF; Coy DH
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1193-8. PubMed ID: 6131435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyr-MIF-1, identified in brain tissue, and its analogs are active in two models of antinociception.
    Kastin AJ; Stephens E; Zadina JE; Coy DH; Fischman AJ
    Pharmacol Biochem Behav; 1985 Dec; 23(6):1045-9. PubMed ID: 2867563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
    Gergen KA; Zadina JE; Paul D
    Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic analogues of Tyr-W-MIF-1 with prolonged analgesic activity and potency comparable to DAMGO and morphine.
    Zadina JE; Kastin AJ; Hackler L; Chang SL
    Peptides; 1994; 15(8):1567-9. PubMed ID: 7700858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic, but not acute, administration of morphine alters antiopiate (Tyr-MIF-1) binding sites in rat brain.
    Zadina JE; Kastin AJ; Ge LJ; Gulden H; Bungart KJ
    Life Sci; 1989; 44(8):555-61. PubMed ID: 2564620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine.
    Banks WA; Kastin AJ
    Peptides; 1994 Jan; 15(1):23-9. PubMed ID: 7912427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Tyr-MIF-1 and MIF-1 at the GABAA receptor chloride channel site.
    Miller LG; Kastin AJ; Roy RB
    Brain Res Bull; 1987 Dec; 19(6):743-5. PubMed ID: 2449939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1.
    Banks WA; Kastin AJ; Ehrensing CA
    J Neurosci Res; 1993 Aug; 35(6):690-5. PubMed ID: 8105102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.